Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk

References

• Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227–53.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, . Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879–85.
   PubMed Web of Science ®Google Scholar
• Siegal S. Benign paroxysmal peritonitis. Ann Intern Med 1945; 23:1–21.
   Web of Science ®Google Scholar
• Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthritis Rheum 2009;61:1447–53.
   PubMed Web of Science ®Google Scholar
• Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, . Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 2005;84:1–11.
   PubMed Web of Science ®Google Scholar
• Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, . Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol 2009;36: 1671–6.
   PubMed Web of Science ®Google Scholar
• Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009;68:246–8.
   PubMed Web of Science ®Google Scholar
• Tchernitchko D, Moutereau S, Legendre M, Delahaye A, Cazeneuve C, Lacombe C, . MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum 2005;52:3603–5.
   PubMed Web of Science ®Google Scholar
• Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, . Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007;56:1706–12.
   PubMed Web of Science ®Google Scholar
• Kuempfel T, Gerdes LA, Wacker T, Blaschek A, Havla J, Krumbholz M, . Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis. Mult Scler. Published online: 15 February 2012. doi:10.1177/1352458512437813.
   Google Scholar
• Heller H, Sohar E, Gafni J, Heller J. Amyloidosis in familial Mediterranean fever. An independent genetically determined character. Arch Intern Med 1961;107:539–50.
   PubMedGoogle Scholar
• Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 1994;37:1804–11.
   PubMed Web of Science ®Google Scholar
• Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986;314:1001–5.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, . Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;356:2361–71.
   PubMed Web of Science ®Google Scholar
• Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991;34:973–7.
   PubMed Web of Science ®Google Scholar
• Bernot A, Clepet C, Dasilva C, Devaud C, Petit JL, Caloustian C, . French FMF consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17:25–31.
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, Centola M, Deng Z, Sood R, Balow JE, Wood G, . The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797–807.
   PubMedGoogle Scholar
• Infevers. The Registry of Hereditary Auto-inflammatory Disorders Mutations http://fmf.igh.cnrs.fr//ISSAID/infevers, (accessed 12 September 2012).
   Google Scholar
• Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 2009;146:467–78.
   PubMed Web of Science ®Google Scholar
• Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, . Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity 2011;34:755–68.
   PubMed Web of Science ®Google Scholar
• Shohat M, Halpern GJ. Familial Mediterranean fever – a review. Genet Med 2011;13:487–98.
   PubMed Web of Science ®Google Scholar
• Majeed HA, El-Shanti H, Al-Khateeb MS, Rabaiha ZA. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum 2002;31:371–6.
   PubMed Web of Science ®Google Scholar
• Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE, . Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000;27:1703–7.
   PubMed Web of Science ®Google Scholar
• Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999;103:e70.
   PubMed Web of Science ®Google Scholar
• Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, . MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype – genetic and therapeutic implications. Am J Hum Genet 1999;65:88–97.
   PubMed Web of Science ®Google Scholar
• Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A, . Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998;6:95–7.
   PubMed Web of Science ®Google Scholar
• Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, . Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999;7:287–92.
   PubMed Web of Science ®Google Scholar
• Pasa S, Altintas A, Devecioglu B, Cil T, Danis R, Isi H, . Familial Mediterranean fever gene mutations in the southeastern region of Turkey and their phenotypical features. Amyloid 2008;15:49–53.
   PubMed Web of Science ®Google Scholar
• Mansour I, Delague V, Cazeneuve C, Dode C, Chouery E, Pecheux C, . Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. Eur J Hum Genet 2001;9:51–5.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, . MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 1999;6:1–6.
   PubMed Web of Science ®Google Scholar
• Balci B, Tinaztepe K, Yilmaz E, Gucer S, Ozen S, Topaloglu R, . MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study. Nephrol Dial Transplant 2002;17:1921–3.
   PubMed Web of Science ®Google Scholar
• Yalcinkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M, . Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology 2000;39:67–72.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, . The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996;26:612–27.
   PubMed Web of Science ®Google Scholar
• Pras E, Livneh A, Balow JE Jr, Kastner DL, Pras M, Langevitz P. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998;75:216–19.
   PubMed Web of Science ®Google Scholar
• Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, . Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 1998;77:268–97.
   PubMed Web of Science ®Google Scholar
• Fragouli E, Eliopoulos E, Petraki E, Sidiropoulos P, Aksentijevich I, Galanakis E, . Familial Mediterranean fever in Crete: a genetic and structural biological approach in a population of ‘intermediate risk’. Clin Genet 2008;73:152–9.
   PubMed Web of Science ®Google Scholar
• La Regina M, Nucera G, Diaco M, Procopio A, Gasbarrini G, Notarnicola C, . Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 2003;11:50–6.
   PubMed Web of Science ®Google Scholar
• Barakat MH, Karnik AM, Majeed HW, el-Sobki NI, Fenech FF. Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs – a study of 175 patients and review of the literature. Q J Med 1986;60:837–47.
   PubMedGoogle Scholar
• Moradian MM, Sarkisian T, Ajrapetyan H, Avanesian N. Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations. J Hum Genet 2010;55:389–93.
   PubMed Web of Science ®Google Scholar
• Aksu K, Keser G. Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int 2011;31:1263–74.
   PubMed Web of Science ®Google Scholar
• Tamir N, Langevitz P, Zemer D, Pras E, Shinar Y, Padeh S, . Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Med Genet 1999;87:30–5.
   PubMed Web of Science ®Google Scholar
• Cefle A, Kamali S, Sayarlioglu M, Inanc M, Ocal L, Aral O, . A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int 2005; 25:442–6.
   PubMed Web of Science ®Google Scholar
• Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, . Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000;67:1136–43.
   PubMed Web of Science ®Google Scholar
• Soylemezoglu O, Arga M, Fidan K, Gonen S, Emeksiz HC, Hasanoglu E, . Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J Rheumatol 2010;37:182–9.
   PubMed Web of Science ®Google Scholar
• Yigit S, Bagci H, Ozkaya O, Ozdamar K, Cengiz K, Akpolat T. MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience [corrected]. J Rheumatol 2008;35:106–13.
   PubMed Web of Science ®Google Scholar
• Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, . Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 2007;119:e474–83.
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Ozdiogan H. Non-response to colchicine in FMF – definition, causes and suggested solutions. Editorial. Clin Exp Rheumatol 2008;26:S49–51.
   PubMed Web of Science ®Google Scholar
• Mor A, Pillinger MH, Kishimoto M, Abeles AM, Livneh A. Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 2007;13:38–40.
   PubMed Web of Science ®Google Scholar
• Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kone-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 2011;41:265–71.
   PubMed Web of Science ®Google Scholar